Huadong Medicine Co., Ltd
000963
Rangering i aksjer
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Aksjekurs
$3.89
Markedsverdi
$6.83B
Endring (1 dag)
-2.22%
Endring (1 år)
-30.58%
Land
CN
Handel Huadong Medicine Co., Ltd (000963)
Kategori
Healthcare
Antall utestående aksjer for Huadong Medicine Co., Ltd (000963)
Antall utestående aksjer per June 2026: 1.75B
Ifølge Huadong Medicine Co., Ltd sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 1.75B. Ved slutten av December 2024 hadde selskapet 1.75B utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Huadong Medicine Co., Ltd (000963) fra 2001 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 1.75B | 0.08% |
| 2025 | 1.75B | 0.02% |
| 2024 | 1.75B | 0.02% |
| 2023 | 1.75B | 0.10% |
| 2022 | 1.75B | 0.00% |
| 2021 | 1.75B | 0.00% |
| 2020 | 1.75B | 0.00% |
| 2019 | 1.75B | -0.44% |
| 2018 | 1.76B | 0.42% |
| 2017 | 1.75B | 0.83% |
| 2016 | 1.74B | 11.22% |
| 2015 | 1.56B | -0.30% |
| 2014 | 1.57B | -0.16% |
| 2013 | 1.57B | 0.10% |
| 2012 | 1.57B | 0.37% |
| 2011 | 1.56B | -0.27% |
| 2010 | 1.56B | -0.34% |
| 2009 | 1.57B | 0.88% |
| 2008 | 1.56B | -0.13% |
| 2007 | 1.56B | 12.06% |
| 2006 | 1.39B | -10.76% |
| 2005 | 1.56B | 0.00% |
| 2004 | 1.56B | 0.00% |
| 2003 | 1.56B | 0.00% |
| 2002 | 1.56B | 0.00% |
| 2001 | 1.56B | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 36.81% |
IN
|
